Mitochondrial topoisomerases and alternative splicing of the human TOP1mt gene

Biochimie

Volumn 89, Issue 4, 2007, Pages 474-481

  Zhang, Hongliang ^a   Meng, Ling Hua ^a   Pommier, Yves ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Alternative splicing; Dual localization; Mitochondrial DNA (mtDNA); Mitochondrial topoisomerase; Top1; Top2; Top3

Indexed keywords

CELL NUCLEUS DNA; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); POLYPEPTIDE; RNA POLYMERASE;

ALTERNATIVE RNA SPLICING; ARTICLE; DNA REPAIR; DNA TRANSCRIPTION; EUKARYOTE; EXON; FLAGELLATE; GENE SEQUENCE; GENE TARGETING; GENETIC CODE; HUMAN; MITOCHONDRIAL DNA REPLICATION; MYOPATHY; NERVE DEGENERATION; NONHUMAN; PLASMODIUM; PREMATURE AGING; SACCHAROMYCES CEREVISIAE; SCHIZOSACCHAROMYCES POMBE;

ALTERNATIVE SPLICING; CATALYSIS; DNA REPLICATION; DNA TOPOISOMERASES, TYPE I; DNA, MITOCHONDRIAL; HUMANS; MITOCHONDRIA; PHYLOGENY; TRANSCRIPTION, GENETIC;

EUKARYOTA; PLASMODIUM (APICOMPLEXA); PROTOZOA; SACCHAROMYCES CEREVISIAE; SCHIZOSACCHAROMYCES POMBE; SCHIZOSACCHAROMYCETACEAE; VERTEBRATA;

EID: 34247344170     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2006.11.002     Document Type: Article

References (67)

1. Champoux J.J. DNA topoisomerases: structure, function, and mechanism. Annu. Rev. Biochem. 70 (2001) 369-413
2. Wang J.C. Cellular roles of DNA topoisomerases: a molecular perspective. Nat Rev Mol. Cell. Biol. 3 (2002) 430-440
3. Samejima K., and Earnshaw W.C. Trashing the genome: the role of nucleases during apoptosis. Nat. Rev. Mol. Cell. Biol. 6 (2005) 677-688
4. Sordet O., Khan Q.A., Plo I., Pourquier P., Urasaki Y., Yoshida A., Antony S., Kohlhagen G., Solary E., Saparbaev M., Laval J., and Pommier Y. Apoptotic topoisomerase I-DNA complexes induced by staurosporine-mediated oxygen radicals. J. Biol. Chem. 279 (2004) 50499-50504
5. Hooper D.C. Mechanisms of action and resistance of older and newer fluoroquinolones. Clin. Infect. Dis. 31 Suppl. 2 (2000) S24-S28
6. Pommier Y. Topoisomerase I inhibitors, camptothecins and beyond. Nat. Rev. Cancer 6 (2006) 789-802
7. Nitiss J.L. DNA topoisomerases in cancer chemotherapy: using enzymes to generate selective DNA damage. Curr. Opin. Invest. Drugs 3 (2002) 1512-1516
8. Li T.K., and Liu L.F. Tumor cell death induced by topoisomerase-targeting drugs. Annu. Rev. Pharmacol. Toxicol. 41 (2001) 53-77
9. Corbett K.D., and Berger J.M. Structure, molecular mechanisms, and evolutionary relationships in DNA topoisomerases. Annu. Rev. Biophys. Biomol. Struct. 33 (2004) 95-118
10. Schapira A.H. Mitochondrial disease. Lancet 368 (2006) 70-82
11. Greaves L.C., and Taylor R.W. Mitochondrial DNA mutations in human disease. IUBMB Life 58 (2006) 143-151
12. Nass M.M., and Nass S. Intramitochondrial fibers with DNA characteristics. I., Fixation and electron staining reactions. J. Cell Biol. 19 (1963) 593-611
13. Shadel G.S., and Clayton D.A. Mitochondrial DNA maintenance in vertebrates. Annu. Rev. Biochem. 66 (1997) 409-435
14. Moraes C.T. What regulates mitochondrial DNA copy number in animal cells?. Trends Genet. 17 (2001) 199-205
15. Garrido N., Griparic L., Jokitalo E., Wartiovaara J., van der Bliek A.M., and Spelbrink J.N. Composition and dynamics of human mitochondrial nucleoids. Mol. Biol. Cell 14 (2003) 1583-1596
16. Kanki T., Nakayama H., Sasaki N., Takio K., Alam T.I., Hamasaki N., and Kang D. Mitochondrial nucleoid and transcription factor A. Ann. N.Y. Acad. Sci. 1011 (2004) 61-68
17. Foury F., Roganti T., Lecrenier N., and Purnelle B. The complete sequence of the mitochondrial genome of Saccharomyces cerevisiae. FEBS Lett. 440 (1998) 325-331
18. Maleszka R., Skelly P.J., and Clark-Walker G.D. Rolling circle replication of DNA in yeast mitochondria. EMBO J. 10 (1991) 3923-3929
19. Friddle R.W., Klare J.E., Martin S.S., Corzett M., Balhorn R., Baldwin E.P., Baskin R.J., and Noy A. Mechanism of DNA compaction by yeast mitochondrial protein Abf2p. Biophys. J. 86 (2004) 1632-1639
20. Brown T.A., and Clayton D.A. Genesis and wanderings: origins and migrations in asymmetrically replicating mitochondrial DNA. Cell Cycle 5 (2006) 917-921
21. Shadel G.S. Coupling the mitochondrial transcription machinery to human disease. Trends Genet. 20 (2004) 513-519
22. McCulloch V., and Shadel G.S. Human mitochondrial transcription factor B1 interacts with the C-terminal activation region of h-mtTFA and stimulates transcription independently of its RNA methyltransferase activity. Mol. Cell. Biol. 23 (2003) 5816-5824
23. Brown T.A., Cecconi C., Tkachuk A.N., Bustamante C., and Clayton D.A. Replication of mitochondrial DNA occurs by strand displacement with alternative light-strand origins, not via a strand-coupled mechanism. Genes Dev. 19 (2005) 2466-2476
24. Yang M.Y., Bowmaker M., Reyes A., Vergani L., Angeli P., Gringeri E., Jacobs H.T., and Holt I.J. Biased incorporation of ribonucleotides on the mitochondrial L-strand accounts for apparent strand-asymmetric DNA replication. Cell 111 (2002) 495-505
25. Yasukawa T., Yang M.Y., Jacobs H.T., and Holt I.J. A bidirectional origin of replication maps to the major noncoding region of human mitochondrial DNA. Mol. Cell 18 (2005) 651-662
26. Castora F.J., and Lazarus G.M. Isolation of a mitochondrial DNA topoisomerase from human leukemia cells. Biochem. Biophys. Res. Commun. 121 (1984) 77-86
27. Kosovsky M.J., and Soslau G. Immunological identification of human platelet mitochondrial DNA topoisomerase I. Biochim. Biophys. Acta. 1164 (1993) 101-107
28. Fairfield F.R., Bauer W.R., and Simpson M.V. Studies on mitochondrial type I topoisomerase and on its function. Biochim. Biophys. Acta. 824 (1985) 45-57
29. Lin J.H., and Castora F.J. Response of purified mitochondrial DNA topoisomerase I from bovine liver to camptothecin and m-AMSA. Arch. Biochem. Biophys. 324 (1995) 293-299
30. Zhang H., Barcelo J.M., Lee B., Kohlhagen G., Zimonjic D.B., Popescu N.C., and Pommier Y. Human mitochondrial topoisomerase I. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 10608-10613
31. D'Arpa P., Machlin P.S., Ratrie III H., Rothfield N.F., Cleveland D.W., and Earnshaw W.C. cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-kDa carboxyl-terminal fragment. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 2543-2547
32. Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G., Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R., Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K., Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C., et al. The sequence of the human genome. Science 291 (2001) 1304-1351
33. Zhang H., Meng L.H., Zimonjic D.B., Popescu N.C., and Pommier Y. Thirteen-exon-motif signature for vertebrate nuclear and mitochondrial type IB topoisomerases. Nucleic Acids Res. 32 (2004) 2087-2092
34. Tanizawa A., Bertrand R., Kohlhagen G., Tabuchi A., Jenkins J., and Pommier Y. Cloning of Chinese Hamster DNA topoisomerase I cDNA and identification of a single point mutation responsible for camptothecin resistance. J. Biol. Chem. 268 (1993) 25463-25468
35. Gupta M., Fujimori A., and Pommier Y. Eukaryotic DNA topoisomerases I. Biochim. Biophys. Acta. 1262 (1995) 1-14
36. Wang Y., Lyu Y.L., and Wang J.C. Dual localization of human DNA topoisomerase IIIalpha to mitochondria and nucleus. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 12114-12119
37. Wang J., Kearney K., Derby M., and Wernette C.M. On the relationship of the ATP-independent, mitochondrial associated DNA topoisomerase of Saccharomyces cerevisiae to the nuclear topoisomerase I. Biochem. Biophys. Res. Commun. 214 (1995) 723-729
38. Tua A., Wang J., Kulpa V., and Wernette C.M. Mitochondrial DNA topoisomerase I of Saccharomyces cerevisiae. Biochimie 79 (1997) 341-350
39. Hanai R., Caron P.R., and Wang J.C. Human TOP3: a single copy gene encoding DNA topoisomerase III. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 3653-3657
40. Li W., and Wang J.C. Mammalian DNA topoisomerase IIIalpha is essential in early embryogenesis. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 1010-1013
41. Plank J.L., Chu S.H., Pohlhaus J.R., Wilson-Sali T., and Hsieh T.S. Drosophila melanogaster topoisomerase IIIalpha preferentially relaxes a positively or negatively supercoiled bubble substrate and is essential during development. J. Biol. Chem. 280 (2005) 3564-3573
42. Castora F.J., Lazarus G.M., and Kunes D. The presence of two mitochondrial DNA topoisomerases in human acute leukemia cells. Biochem. Biophys. Res. Commun. 130 (1985) 854-866
43. Lin J.H., and Castora F.J. DNA topoisomerase II from mammalian mitochondria is inhibited by the antitumor drugs, m-AMSA and VM-26. Biochem. Biophys. Res. Commun. 176 (1991) 690-697
44. Low R.L., Orton S., and Friedman D.B. A truncated form of DNA topoisomerase IIbeta associates with the mtDNA genome in mammalian mitochondria. Eur. J. Biochem. 270 (2003) 4173-4186
45. Kulikowicz T., and Shapiro T.A. Distinct genes encode type II Topoisomerases for the nucleus and mitochondrion in the protozoan parasite Trypanosoma brucei. J. Biol. Chem. 281 (2006) 3048-3056
46. Das B.B., Sengupta T., Ganguly A., and Majumder H.K. Topoisomerases of kinetoplastid parasites: why so fascinating?. Mol. Microbiol. 62 (2006) 917-927
47. Douc-Rasy S., Riou J.F., Ahomadegbe J.C., and Riou G. ATP-independent DNA topoisomerase II as potential drug target in trypanosomes. Biol. Cell 64 (1988) 145-156
48. Chakraborty A.K., and Majumder H.K. Decatenation of kinetoplast DNA by an ATP-dependent DNA topoisomerase from the kinetoplast hemoflagellate Leishmania donovani. Mol. Biochem. Parasitol. 26 (1987) 215-224
49. Chakraborty A.K., and Majumder H.K. An ATP-independent catenating enzyme from the kinetoplast hemoflagellate Leishmania donovani. Biochem. Biophys. Res. Commun. 180 (1991) 279-285
50. Melendy T., and Ray D.S. Novobiocin affinity purification of a mitochondrial type II topoisomerase from the trypanosomatid Crithidia fasciculata. J. Biol. Chem. 264 (1989) 1870-1876
51. Melendy T., Sheline C., and Ray D.S. Localization of a type II DNA topoisomerase to two sites at the periphery of the kinetoplast DNA of Crithidia fasciculata. Cell 55 (1988) 1083-1088
52. Fragoso S.P., Mattei D., Hines J.C., Ray D., and Goldenberg S. Expression and cellular localization of Trypanosoma cruzi type II DNA topoisomerase. Mol. Biochem. Parasitol. 94 (1998) 197-204
53. Wang Z., and Englund P.T. RNA interference of a trypanosome topoisomerase II causes progressive loss of mitochondrial DNA. EMBO J. 20 (2001) 4674-4683
54. Strauss P.R., and Wang J.C. The TOP2 gene of Trypanosoma brucei: a single-copy gene that shares extensive homology with other TOP2 genes encoding eukaryotic DNA topoisomerase II. Mol. Biochem. Parasitol. 38 (1990) 141-150
55. Das A., Dasgupta A., Sharma S., Ghosh M., Sengupta T., Bandopadhyay S., and Majumder H.K. Characterisation of the gene encoding type II DNA topoisomerase from Leishmania donovani: a key molecular target in antileishmanial therapy. Nucleic Acids Res. 29 (2001) 1844-1851
56. Pasion S.G., Hines J.C., Aebersold R., and Ray D.S. Molecular cloning and expression of the gene encoding the kinetoplast-associated type II DNA topoisomerase of Crithidia fasciculata. Mol. Biochem. Parasitol. 50 (1992) 57-67
57. Fragoso S.P., and Goldenberg S. Cloning and characterization of the gene encoding Trypanosoma cruzi DNA topoisomerase II. Mol. Biochem. Parasitol. 55 (1992) 127-134
58. Hanke T., Ramiro M.J., Trigueros S., Roca J., and Larraga V. Cloning, functional analysis and post-transcriptional regulation of a type II DNA topoisomerase from Leishmania infantum. A new potential target for anti-parasite drugs. Nucleic Acids Res. 31 (2003) 4917-4928
59. De Sousa J.M., Lareau S.M., Pearson R.D., Carvalho E.M., Mann B.J., and Jeronimo S.M. Characterization of Leishmania chagasi DNA topoisomerase II: a potential chemotherapeutic target. Scand. J. Infect. Dis. 35 (2003) 826-829
60. Bodley A.L., Chakraborty A.K., Xie S., Burri C., and Shapiro T.A. An unusual type IB topoisomerase from African trypanosomes. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 7539-7544
61. Davies D.R., Mushtaq A., Interthal H., Champoux J.J., and Hol W.G. The structure of the transition state of the heterodimeric topoisomerase I of Leishmania donovani as a vanadate complex with nicked DNA. J. Mol. Biol. 357 (2006) 1202-1210
62. Villa H., Otero Marcos A.R., Reguera R.M., Balana-Fouce R., Garcia-Estrada C., Perez-Pertejo Y., Tekwani B.L., Myler P.J., Stuart K.D., Bjornsti M.A., and Ordonez D. A novel active DNA topoisomerase I in Leishmania donovani. J. Biol. Chem. 278 (2003) 3521-3526
63. Bakshi R.P., and Shapiro T.A. RNA interference of Trypanosoma brucei topoisomerase IB: both subunits are essential. Mol. Biochem. Parasitol. 136 (2004) 249-255
64. Bodley A.L., and Shapiro T.A. Molecular and cytotoxic effects of camptothecin, a topoisomerase I inhibitor, on trypanosomes and Leishmania. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 3726-3730
65. Balana-Fouce R., Redondo C.M., Perez-Pertejo Y., Diaz-Gonzalez R., and Reguera R.M. Targeting atypical trypanosomatid DNA topoisomerase I. Drug Discov. Today 11 (2006) 733-740
66. Riou G., and Delain E. Electron microscopy of the circular kinetoplastic DNA from Trypanosoma cruzi: occurrence of catenated forms. Proc. Natl. Acad. Sci. U.S.A. 62 (1969) 210-217
67. Fujimori A., Gupta M., Hoki Y., and Pommier Y. Acquired camptothecin resistance of human breast cancer MCF-7/C4 cells with normal topoisomerase I and elevated DNA repair. Mol. Pharmacol. 50 (1996) 1472-1478